Spectrum Pharmaceuticals, Inc. (SPPI)의 가격은 얼마입니까?

Spectrum Pharmaceuticals, Inc. (SPPI)의 가격은 $1.03입니다.

Spectrum Pharmaceuticals, Inc. (SPPI)의 시가 총액은 무엇입니까?

Spectrum Pharmaceuticals, Inc. (SPPI)의 시가 총액은 $115.13M입니다.

Spectrum Pharmaceuticals, Inc. (SPPI) 배당수익률

Spectrum Pharmaceuticals, Inc. operates as a biopharmaceutical firm, primarily engaged in the research, development, and market introduction of innovative drug products for cancer and blood disorders. Its robust pipeline features Eflapegrastim, an advanced, long-acting granulocyte colony-stimulating factor designed to address chemotherapy-induced neutropenia. Also under development is Poziotinib, a distinct irreversible tyrosine kinase inhibitor intended for non-small cell lung cancer tumors exhibiting various mutations. Furthermore, Anti-CD20-IFNa, an antibody-interferon fusion molecule targeting CD20, is progressing through Phase I development for patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. The company maintains key collaborative agreements, such as co-development, commercialization, and in-licensing arrangements with Hanmi Pharmaceutical Co. Ltd., a patent and technology license with The University of Texas M.D. Anderson Cancer Center, and an in-license pact with ImmunGene, Inc. Founded in 1987, and initially known as NeoTherapeutics, Inc. before its name change in December 2002, Spectrum Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.

연도	배당 수익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

배당 수익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	배당 수익률	국가
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Moderna, Inc. MRNA.US	0.00%	US
CSL Limited CSL.AX	3.12%	AU
Lonza Group AG LONN.SW	0.00%	CH

회사

배당 수익률

국가